Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medha Barbhaiya

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Current Rheumatology Reports|September 10, 2013
Top 10 clinical research developments in antiphospholipid syndromeMedha Barbhaiya, Doruk Erkan
Current Rheumatology Reports|November 25, 2010
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Medha Barbhaiya, Doruk Erkan
The Journal of Rheumatology|January 3, 2013
The optimal tool for assessment of organ damage in antiphospholipid syndromeMedha Barbhaiya, Doruk Erkan
Current Opinion in Rheumatology|July 19, 2016
Environmental exposures and the development of systemic lupus erythematosusMedha Barbhaiya, Karen H Costenbader
Clinical Immunology (Orlando, Fla.)|June 19, 2013
Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancyMedha Barbhaiya, Bonnie L Bermas
Annals of Internal Medicine|October 26, 2021
B-Cell Targeted Therapeutics in Systemic Lupus Erythematosus: From Paradox to Synergy?Medha Barbhaiya, Katherine P Liao
Current Opinion in Rheumatology|March 8, 2013
Rheumatoid arthritis and cardiovascular disease: an update on treatment issuesMedha Barbhaiya, Daniel H Solomon
Current Rheumatology Reports|September 12, 2018
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?Yu Zuo, Medha Barbhaiya, Doruk Erkan
Current Rheumatology Reports|September 21, 2016
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year UpdateMedha Barbhaiya, Danieli Andrade, Doruk Erkan, et al.
ACR Open Rheumatology|November 22, 2021
When a Diagnosis Has No Name: Uncertainty and OpportunityMichael D Lockshin, Mary K Crow, Medha Barbhaiya
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Current Rheumatology Reports|September 10, 2013
Top 10 clinical research developments in antiphospholipid syndromeMedha Barbhaiya, Doruk Erkan
Current Rheumatology Reports|November 25, 2010
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Medha Barbhaiya, Doruk Erkan
The Journal of Rheumatology|January 3, 2013
The optimal tool for assessment of organ damage in antiphospholipid syndromeMedha Barbhaiya, Doruk Erkan
Current Opinion in Rheumatology|July 19, 2016
Environmental exposures and the development of systemic lupus erythematosusMedha Barbhaiya, Karen H Costenbader
Clinical Immunology (Orlando, Fla.)|June 19, 2013
Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancyMedha Barbhaiya, Bonnie L Bermas
Annals of Internal Medicine|October 26, 2021
B-Cell Targeted Therapeutics in Systemic Lupus Erythematosus: From Paradox to Synergy?Medha Barbhaiya, Katherine P Liao
Current Opinion in Rheumatology|March 8, 2013
Rheumatoid arthritis and cardiovascular disease: an update on treatment issuesMedha Barbhaiya, Daniel H Solomon
Current Rheumatology Reports|September 12, 2018
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?Yu Zuo, Medha Barbhaiya, Doruk Erkan
Current Rheumatology Reports|September 21, 2016
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year UpdateMedha Barbhaiya, Danieli Andrade, Doruk Erkan, et al.
ACR Open Rheumatology|November 22, 2021
When a Diagnosis Has No Name: Uncertainty and OpportunityMichael D Lockshin, Mary K Crow, Medha Barbhaiya
Pageof 9